Company / R&D Expense
Dentsply Sirona R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$150.0M
FY2025
5-year range
$150.0M / $184.0M
FY2021-FY2025
Trend
-9.1%
vs FY2024
Sector context
#45 of 105
Health Care
What the data says
At $150M, Dentsply Sirona's r&d expense ranks #45 of 105 in the Health Care sector. R&D Expense has fluctuated over the past 10 years, ranging from $123M in FY2020 to $184M in FY2023.
Based on SEC 10-K filings.
$150M in FY2025 with a 5-year CAGR of +4.0%.
Declined from $184M to $150M over the past 2 years.
Health Care sector context is included.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -4.8%
- 5-Year CAGR
- +4.0%
- 10-Year CAGR
- -
Sector benchmark
#45 of 105 in Health CareTop 43% of 105This company $150.0M Sector average $284.2M
▼
-47.2% below sector average
Key checks
Key Insights
- 5-year CAGR of +4.0%, indicating consistent growth.
- In FY2025, r&d expense decreased 9.1% year-over-year.
- Ranks #45 out of 105 companies in the Health Care sector.
- Peak r&d expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.42 (distress zone, below 1.8 threshold)
- Negative profit margin: -24.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $150.0M | -9.1% |
| FY2024 | $165.0M | -10.3% |
| FY2023 | $184.0M | +5.7% |
| FY2022 | $174.0M | +1.8% |
| FY2021 | $171.0M | +39.0% |
| FY2020 | $123.0M | -14.0% |
| FY2019 | $143.0M | -11.2% |
| FY2018 | $161.0M | +6.1% |
| FY2017 | $151.7M | +18.1% |
| FY2016 | $128.5M | +71.6% |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026